Chemotherapy for leukemia uses drugs that kill rapidly dividing cells to clear leukemic cells from the blood and bone marrow so that normal blood production can recover. For acute leukemias it is usually given in planned phases (induction, consolidation and sometimes maintenance) over months to years. For chronic leukemias it has largely been replaced or supplemented by targeted drugs. The regimen you receive depends on the leukemia subtype, its genetic features, and your age and overall fitness.
If you or someone close to you has just been told chemotherapy is the next step, this guide walks through how it works, what each phase is for, which side effects to watch for, and where newer therapies fit in.
What Leukemia Is and Why Chemotherapy Works
Leukemia is a cancer of the blood-forming cells in the bone marrow. Acquired mutations in DNA cause immature cells to multiply without the usual checks on growth and death. These cells crowd out healthy marrow and spill into the blood as large numbers of abnormal white blood cells.
Chemotherapy drugs are cytotoxic. They damage DNA or block cell division, so they hit fast-dividing cells hardest. Leukemic cells are the main target. Healthy fast-dividing cells in the marrow, gut lining and hair follicles are affected too, and that explains most side effects.
The goal of the first phase is complete remission. That means blood counts recover, fewer than 5% of marrow cells are blasts, and there is no leukemia outside the marrow. Remission is not the same as cure. That is why treatment continues after it.
Diagnosis Comes First: Why Subtype Matters
No regimen is chosen until the leukemia has been precisely classified. The diagnosis of leukemia starts with a complete blood count and blood smear. It is then confirmed by bone marrow aspiration and biopsy.
Flow cytometry, cytogenetics and molecular testing identify the cell type and key mutations. This range of leukemia diagnosis tests matters because the four main types behave very differently. For a broader view of testing for leukemia in adults, including follow-up testing during treatment, see our dedicated article.
| Leukemia type | Typical role of chemotherapy | Commonly used agents |
|---|---|---|
| Acute lymphoblastic leukemia (ALL) | Central; multi-phase treatment lasting about two to three years | Vincristine, corticosteroids, anthracyclines, asparaginase, methotrexate, 6-mercaptopurine |
| Acute myeloid leukemia (AML) | Central for fit patients; intensive induction then consolidation | Cytarabine plus an anthracycline (daunorubicin or idarubicin) |
| Chronic myeloid leukemia (CML) | Rarely needed; tyrosine kinase inhibitors are first-line | Imatinib and related oral drugs (targeted, not classic chemotherapy) |
| Chronic lymphocytic leukemia (CLL) | Now used less often; targeted drugs usually preferred | Historically fludarabine, cyclophosphamide and rituximab |
The Phases of Chemotherapy for Leukemia
Acute leukemia treatment is built in stages. Each stage has a different job, and together they aim to treat leukemia thoroughly enough to prevent relapse.
Induction
Induction is the most intensive phase, usually given in hospital. In AML, the classic regimen is known as “7+3”: seven days of continuous cytarabine infusion with three days of an anthracycline. In ALL, induction typically combines vincristine, a corticosteroid, an anthracycline and asparaginase over about four weeks.
Consolidation (Intensification)
Consolidation begins once remission is reached. It targets the small number of leukemic cells that remain but can’t be seen under the microscope. In AML this often means cycles of higher-dose cytarabine. Some patients move on to a stem cell transplant instead.
Maintenance
Maintenance is mainly used in ALL. It involves low-intensity, mostly oral chemotherapy such as daily 6-mercaptopurine and weekly methotrexate, continued for roughly two years. It is usually given at home and lets most people return to school or work.
CNS-Directed Therapy
Some leukemias, particularly ALL, can hide in the fluid around the brain and spinal cord. Intrathecal chemotherapy is injected into the spinal fluid by lumbar puncture, often methotrexate, and is given throughout treatment to prevent relapse there.
How Chemotherapy Is Given
Drugs may be given intravenously, by mouth, under the skin, or intrathecally. Intensive regimens usually need a central venous catheter, such as a PICC line or port. This avoids repeated needle sticks and protects veins from irritating drugs.
Treatment runs in cycles: a period of drug delivery followed by a recovery period. Blood counts usually fall to their lowest point, the nadir, roughly 7 to 14 days after a cycle. After that, the marrow gradually recovers.
Side Effects and How They Are Managed
Most side effects come from damage to healthy fast-dividing cells. They are expected, monitored closely, and usually temporary.
- Low blood counts (myelosuppression): A low neutrophil count raises infection risk. Low hemoglobin causes fatigue, and low platelets cause bruising or bleeding. Transfusions and growth factors help carry patients through the nadir.
- Neutropenic fever: A temperature of 38.0 °C (100.4 °F) or higher while neutrophils are low is a medical emergency that needs same-day antibiotics.
- Tumor lysis syndrome: When many leukemic cells break down at once, potassium, phosphate and uric acid levels rise. This can harm the kidneys, so fluids and preventive medicines are given with induction.
- Mouth sores, nausea and hair loss: These are common and usually managed well with mouth care and modern anti-sickness drugs. Hair regrows after treatment.
- Drug-specific effects: Anthracyclines can affect heart muscle, so heart function is checked before treatment. Vincristine can cause tingling or numbness in the hands and feet.
In my practice, the side effect that most often catches families off guard is how quickly a fever can become serious during the nadir. Every patient should leave with a written plan saying exactly whom to call and when.
Where Targeted Therapy and Immunotherapy Fit In
Chemotherapy is still the backbone for most acute leukemias, but it is increasingly combined with more precise drugs. Tyrosine kinase inhibitors block the BCR-ABL protein in CML and in Philadelphia chromosome-positive ALL, and they transformed outcomes in both.
Other targeted agents act on specific mutations in AML. Monoclonal antibodies and CAR T-cell therapy use the immune system against leukemia, especially in relapsed ALL. Older or less fit patients may receive gentler combinations that pair low-intensity chemotherapy with a targeted drug.
When to See a Doctor
During chemotherapy, contact your treating team straight away if you notice:
- A temperature of 38.0 °C (100.4 °F) or higher, or shaking chills
- Bleeding that won’t stop, blood in urine or stool, or new widespread bruising
- Shortness of breath, chest pain, or severe dizziness
- Vomiting or diarrhea that prevents you from keeping fluids down
- Confusion, severe headache, or a marked drop in urine output
Frequently Asked Questions
How long does chemotherapy for leukemia last?
It depends on the type. AML treatment with induction and consolidation usually takes several months. ALL treatment, including maintenance, commonly lasts about two to three years. Chronic leukemias are often managed with ongoing oral targeted therapy rather than fixed chemotherapy courses.
Can chemotherapy cure leukemia?
For some patients, yes. Many children with ALL and a proportion of adults with acute leukemia are cured with chemotherapy alone or combined with a stem cell transplant. Your hematologist can explain what is realistic based on your subtype and genetic findings.
Will I need to stay in hospital?
Intensive induction for acute leukemia usually means several weeks in hospital while counts are at their lowest. Consolidation cycles may be given as an inpatient or outpatient, and maintenance is typically taken at home.
Is chemotherapy always the first treatment?
No. CML is treated first with tyrosine kinase inhibitors. Early CLL without symptoms is often simply monitored. When CLL does need treatment, targeted oral drugs are commonly chosen ahead of chemotherapy.
For a structured overview of every leukemia type, visit our leukemia guide.
